Filippo Crea
doi : 10.1093/eurheartj/ehab485
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2871–2875
Riccardo Di Pietro, Simone Calcagno, Giuseppe Biondi-Zoccai, Francesco Versaci
doi : 10.1093/eurheartj/ehab083
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2876–2879
Mark Nicholls
doi : 10.1093/eurheartj/ehab318
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2880–2881
O Alfieri, J Chikwe, M Czerny
doi : 10.1093/eurheartj/ehab270
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Page 2882
Leonarda Galiuto, Carlo Patrono
doi : 10.1093/eurheartj/ehab387
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2883–2884
Michal Cohen-Shelly, Zachi I Attia, Paul A Friedman, Saki Ito, Benjamin A Essayagh, Wei-Yin Ko, Dennis H Murphree, Hector I Michelena, Maurice Enriquez-Sarano, Rickey E Carter, Patrick W Johnson, Peter A Noseworthy, Francisco Lopez-Jimenez, Jae K Oh
doi : 10.1093/eurheartj/ehab153
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2885–2896
Early detection of aortic stenosis (AS) is becoming increasingly important with a better outcome after aortic valve replacement in asymptomatic severe AS patients and a poor outcome in moderate AS. We aimed to develop artificial intelligence-enabled electrocardiogram (AI-ECG) using a convolutional neural network to identify patients with moderate to severe AS.
Joon-myoung Kwon, Yong-Yeon Jo, Soo Youn Lee, Kyung-Hee Kim
doi : 10.1093/eurheartj/ehab090
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2896–2898
Jarl Emanuel Strange, Anders Holt, Paul Blanche, Gunnar Gislason, Christian- Torp-Pedersen, Daniel M?lager Christensen, Morten Lock Hansen, Morten Lamberts, Morten Schou, Jonas Bjerring Olesen, Emil Loldrup Fosb?l, Lars K?ber, Peter Vibe Rasmussen
doi : 10.1093/eurheartj/ehab374
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2899–2908
Reports have suggested an increased risk of aortic and mitral regurgitation associated with oral fluoroquinolones (FQs) resulting in a safety warning published by the European Medicines Agency (EMA). However, these findings have not yet been replicated.
Juan Tamargo, Stefan Agewall
doi : 10.1093/eurheartj/ehab426
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2909–2911
Troels H?jsgaard J?rgensen, Hans Gustav H?rsted Thyregod, Nikolaj Ihlemann, Henrik Nissen, Petur Petursson, Bo Juel Kjeldsen, Daniel Andreas Steinbrüchel, Peter Skov Olsen, Lars S?ndergaard
doi : 10.1093/eurheartj/ehab375
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2912–2919
The aims of the study were to compare clinical outcomes and valve durability after 8 years of follow-up in patients with symptomatic severe aortic valve stenosis at low surgical risk treated with either transcatheter aortic valve implantation (TAVI) or surgical aortic valve replacement (SAVR).
Shakirat O Oyetunji, Catherine M Otto
doi : 10.1093/eurheartj/ehab393
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2920–2923
Julie H?gh, Michael Huy Cuong Pham, Andreas Dehlb?k Knudsen, Rebekka Faber Thudium, Marco Gelpi, Per Ejlstrup Sigvardsen, Andreas Fuchs, , J?rgen Tobias Kühl, Shoaib Afzal, B?rge Gr?nne Nordestgaard, Thomas Benfield, Lars K?ber, Jan Gerstoft, Klaus Fuglsang Kofoed, Susanne Dam Nielsen
doi : 10.1093/eurheartj/ehab348
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2924–2931
Little is known about the prevalence of aortic aneurysms among people living with HIV (PLWH). We investigated whether HIV status is independently associated with having aortic aneurysms. Furthermore, we determined risk factors associated with aortic aneurysms in PLWH.
Priscilla Y Hsue
doi : 10.1093/eurheartj/ehab429
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2932–2934
Yongjun Wang, Dong Han, Tingwen Zhou, Cheng Chen, Hong Cao, Joe Z Zhang, Ning Ma, Chun Liu, Moshi Song, Jiawei Shi, Xin Jin, Feng Cao, Nianguo Dong
doi : 10.1093/eurheartj/ehab316
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2935–2951
The morbidity and mortality rates of calcific aortic valve disease (CAVD) remain high while treatment options are limited. Here, we evaluated the role and therapeutic value of dual-specificity phosphatase 26 (DUSP26) in CAVD.
Maximillian A Rogers, Elena Aikawa
doi : 10.1093/eurheartj/ehab381
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2948–2950
Robert Sykes, Andrew Morrow, Kenneth Mangion
doi : 10.1093/eurheartj/ehab238
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2951–2952
Tushar Kotecha, Daniel S Knight, James C Moon, Graham D Cole, Marianna Fontana
doi : 10.1093/eurheartj/ehab240
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Pages 2953–2954
Brian C Case, Itsik Ben-Dor, Lowell F Satler, Ron Waksman, Toby Rogers
doi : 10.1093/eurheartj/ehab112
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Page 2955
Tayyub Yasin, Jing Yong Ng, Angela Gallagher, Mohammed Y Khanji
doi : 10.1093/eurheartj/ehab174
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Page 2956
Naser Gharebaghi, Hamid Mehdizade, Behnam Askari, Mohammad Mirza-Aghazadeh-Attari, MirHossein Seyed-Mohammadzad, Afshin Mohammadi, Kamal Khademvatani
doi : 10.1093/eurheartj/ehab258
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Page 2957
doi : 10.1093/eurheartj/ehab455
European Heart Journal, Volume 42, Issue 30, 7 August 2021, Page 2954
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟